Pharmacol-话题@MedSci

#Pharmacol#

378篇内容 | 2340人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1788365, encodeId=02511e8836504, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Int Immunopharmacol：TLR4拮抗剂能够减轻并发过敏性鼻炎和哮喘综合症, objectType=article, longId=167914, objectId=c16616e91458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c16616e91458, replyNumber=0, likeNumber=65, createdTime=2019-12-08, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c16616e91458, moduleTitle=Int Immunopharmacol：TLR4拮抗剂能够减轻并发过敏性鼻炎和哮喘综合症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c16616e91458)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788370, encodeId=0ef91e883703f, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Pharmacology：萝卜硫素可逆转氧化应激对成骨细胞活性和矿化的抑制作用, objectType=article, longId=176577, objectId=2b9d1e65771e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b9d1e65771e, replyNumber=0, likeNumber=55, createdTime=2019-08-06, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b9d1e65771e, moduleTitle=Pharmacology：萝卜硫素可逆转氧化应激对成骨细胞活性和矿化的抑制作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b9d1e65771e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788376, encodeId=bad11e88376d0, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Frontiers in Pharmacology：LPV/r一线治疗HIV感染研究结果发表, objectType=article, longId=186098, objectId=1cee18609806, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cee18609806, replyNumber=0, likeNumber=60, createdTime=2020-04-10, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cee18609806, moduleTitle=Frontiers in Pharmacology：LPV/r一线治疗HIV感染研究结果发表, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cee18609806)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788375, encodeId=e3621e883753c, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Frontier in Pharmacology：HIV感染者使用LPV/r二线治疗的长期、大规模、多中心、真实世界研究结果发布, objectType=article, longId=186097, objectId=245d18609efa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245d18609efa, replyNumber=0, likeNumber=62, createdTime=2020-12-26, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245d18609efa, moduleTitle=Frontier in Pharmacology：HIV感染者使用LPV/r二线治疗的长期、大规模、多中心、真实世界研究结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=245d18609efa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788369, encodeId=1e6b1e8836971, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症, objectType=article, longId=176305, objectId=2c551e63051c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c551e63051c, replyNumber=0, likeNumber=70, createdTime=2020-05-07, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c551e63051c, moduleTitle=Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c551e63051c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788368, encodeId=75de1e8836819, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展, objectType=article, longId=175404, objectId=17361e54044b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17361e54044b, replyNumber=0, likeNumber=60, createdTime=2020-02-11, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17361e54044b, moduleTitle=Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17361e54044b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788362, encodeId=28b81e8836223, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Front Pharmacol：基于洛匹那韦/利托那韦的**和替代二线方案在HIV感染患者中的疗效, objectType=article, longId=164255, objectId=4e0616425517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e0616425517, replyNumber=0, likeNumber=64, createdTime=2019-04-29, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e0616425517, moduleTitle=Front Pharmacol：基于洛匹那韦/利托那韦的**和替代二线方案在HIV感染患者中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e0616425517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788358, encodeId=9acf1e883584a, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Acta Pharmacol Sin：中国人群血清尿酸水平与骨质疏松症和骨转换指标的关系, objectType=article, longId=160253, objectId=1d6b160253fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d6b160253fa, replyNumber=0, likeNumber=56, createdTime=2019-12-12, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d6b160253fa, moduleTitle=Acta Pharmacol Sin：中国人群血清尿酸水平与骨质疏松症和骨转换指标的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d6b160253fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788355, encodeId=f2941e8835577, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Front Pharmacol：富含类黄酮的佛手柑汁提取物改善脂多糖诱导的牙周炎, objectType=article, longId=159590, objectId=c3a1159590ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3a1159590ca, replyNumber=0, likeNumber=87, createdTime=2019-12-29, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3a1159590ca, moduleTitle=Front Pharmacol：富含类黄酮的佛手柑汁提取物改善脂多糖诱导的牙周炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3a1159590ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788357, encodeId=007a1e88357c7, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Neuropsychopharmacology：女性荷尔蒙在成瘾中的作用：复发率更高, objectType=article, longId=159793, objectId=e610159e932e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e610159e932e, replyNumber=0, likeNumber=62, createdTime=2019-02-25, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e610159e932e, moduleTitle=Neuropsychopharmacology：女性荷尔蒙在成瘾中的作用：复发率更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e610159e932e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788373, encodeId=ed9d1e8837332, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险, objectType=article, longId=181662, objectId=2258181662f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2258181662f7, replyNumber=0, likeNumber=56, createdTime=2019-12-05, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2258181662f7, moduleTitle=Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2258181662f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788350, encodeId=d1931e88350df, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Int Immunopharmacol：蛋氨酸脑啡肽（MENK）对髓样抑制细胞（MDSCs）进行调节的新机制, objectType=article, longId=158554, objectId=b3ba15855463, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3ba15855463, replyNumber=0, likeNumber=76, createdTime=2019-07-11, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3ba15855463, moduleTitle=Int Immunopharmacol：蛋氨酸脑啡肽（MENK）对髓样抑制细胞（MDSCs）进行调节的新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3ba15855463)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788351, encodeId=bb501e883513f, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症, objectType=article, longId=159002, objectId=515c159002e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=515c159002e4, replyNumber=0, likeNumber=44, createdTime=2019-03-28, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=515c159002e4, moduleTitle=Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=515c159002e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788330, encodeId=6bd61e8833042, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Eur Rev Med Pharmacol Sci：MiR-203是绝经后骨质疏松症中间充质干细胞分化的重要因子, objectType=article, longId=150549, objectId=dbad1505497d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbad1505497d, replyNumber=0, likeNumber=77, createdTime=2019-01-28, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbad1505497d, moduleTitle=Eur Rev Med Pharmacol Sci：MiR-203是绝经后骨质疏松症中间充质干细胞分化的重要因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbad1505497d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788337, encodeId=dd731e8833739, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=J Clin Pharmacol：在前列腺癌患者中，雄激素阻断治疗能够增加心脏衰竭的风险, objectType=article, longId=154190, objectId=ce141541905c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce141541905c, replyNumber=0, likeNumber=60, createdTime=2019-08-25, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce141541905c, moduleTitle=J Clin Pharmacol：在前列腺癌患者中，雄激素阻断治疗能够增加心脏衰竭的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce141541905c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788371, encodeId=dd071e88371ef, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡, objectType=article, longId=177301, objectId=41851e73015c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41851e73015c, replyNumber=0, likeNumber=47, createdTime=2020-07-16, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41851e73015c, moduleTitle=Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41851e73015c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788328, encodeId=db1e1e88328bc, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=J Ocul Pharmacol Ther：2％多佐胺和0.5％噻吗洛尔（COSOPT）冷藏使用比常温使用具有较少的眼部不适, objectType=article, longId=149403, objectId=5d0f149403e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d0f149403e6, replyNumber=0, likeNumber=64, createdTime=2019-06-10, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d0f149403e6, moduleTitle=J Ocul Pharmacol Ther：2％多佐胺和0.5％噻吗洛尔（COSOPT）冷藏使用比常温使用具有较少的眼部不适, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d0f149403e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788359, encodeId=66891e883593e, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Front Pharmacol：可溶性环氧化物水解酶抑制眼部疾病的展望, objectType=article, longId=162987, objectId=922416298e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=922416298e0b, replyNumber=0, likeNumber=47, createdTime=2020-01-02, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=922416298e0b, moduleTitle=Front Pharmacol：可溶性环氧化物水解酶抑制眼部疾病的展望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=922416298e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788366, encodeId=84e21e8836626, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Front Pharmacol：氯化铷可用于植入物表面涂层促进骨整合, objectType=article, longId=168540, objectId=a263168540ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a263168540ab, replyNumber=0, likeNumber=61, createdTime=2019-09-25, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a263168540ab, moduleTitle=Front Pharmacol：氯化铷可用于植入物表面涂层促进骨整合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a263168540ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1788344, encodeId=badb1e8834421, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, objectTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, objectType=article, longId=156509, objectId=fcba1565093c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcba1565093c, replyNumber=0, likeNumber=56, createdTime=2019-11-08, rootId=0, userName=dingxiaobo, userId=930e243, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcba1565093c, moduleTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcba1565093c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Pharmacol

2020-05-29

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Int Immunopharmacol：TLR4拮抗剂能够减轻并发过敏性鼻炎和哮喘综合症

2019-12-08

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Pharmacology：萝卜硫素可逆转氧化应激对成骨细胞活性和矿化的抑制作用

2019-08-06

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Frontiers in Pharmacology：LPV/r一线治疗HIV感染研究结果发表

2020-04-10

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Frontier in Pharmacology：HIV感染者使用LPV/r二线治疗的长期、大规模、多中心、真实世界研究结果发布

2020-12-26

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症

2020-05-07

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展

2020-02-11

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Front Pharmacol：基于洛匹那韦/利托那韦的**和替代二线方案在HIV感染患者中的疗效

2019-04-29

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Acta Pharmacol Sin：中国人群血清尿酸水平与骨质疏松症和骨转换指标的关系

2019-12-12

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Front Pharmacol：富含类黄酮的佛手柑汁提取物改善脂多糖诱导的牙周炎

2019-12-29

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Neuropsychopharmacology：女性荷尔蒙在成瘾中的作用：复发率更高

2019-02-25

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险

2019-12-05

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Int Immunopharmacol：蛋氨酸脑啡肽（MENK）对髓样抑制细胞（MDSCs）进行调节的新机制

2019-07-11

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症

2019-03-28

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Eur Rev Med Pharmacol Sci：MiR-203是绝经后骨质疏松症中间充质干细胞分化的重要因子

2019-01-28

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

J Clin Pharmacol：在前列腺癌患者中，雄激素阻断治疗能够增加心脏衰竭的风险

2019-08-25

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡

2020-07-16

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

J Ocul Pharmacol Ther：2％多佐胺和0.5％噻吗洛尔（COSOPT）冷藏使用比常温使用具有较少的眼部不适

2019-06-10

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Front Pharmacol：可溶性环氧化物水解酶抑制眼部疾病的展望

2020-01-02

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Front Pharmacol：氯化铷可用于植入物表面涂层促进骨整合

2019-09-25

dingxiaobo (审核中...)

前往app查看评论内容

#Pharmacol#

Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？

2019-11-08

科室
- - 订阅+
  - 更多科室
工具
服务